DarioHealth Corp. amended its credit agreement on November 5, 2025, to reset financial covenants and include a $10 million liquidity requirement, along with a $150,000 amendment fee. The amendment also lowers the warrant exercise price from $16.556 to $15.3495 per share, making it a significant event for the company.